Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

Aiforia

Helsinki Healthtech Startup Aiforia Secures €20 Million in EIB Venture Debt for AI Diagnostics Expansion

August 3, 2026 by Lars Eriksson

Helsinki‑based AI life‑science startup Aiforia obtained €20 million of venture debt from the European Investment Bank, backed by the EU InvestEU programme, to speed up its AI‑driven cancer diagnostic platform and grow its global commercial presence.

Categories Funding Tags €20M–€100M, Aiforia, Finland, Growth, Healthtech Leave a comment
Browse by Country

Latest

Swedish Murder-Mystery Game Maker Arkiv Reaches 30 Million SEK in Sales Within Two YearsAug 8, 2026
Romanian Betting Platform Super Technologies Reaches Unicorn Status with €1.3 Billion Investment from Blackstone and HPS InvestmentAug 7, 2026
Budbee Founders Launch Hemla Security Startup With Ambitious Vision, But Full Rollout Delayed to 2025Aug 7, 2026
Polish Game Studio Funventure Secures $1 Million Bridge Round for Platform DevelopmentAug 7, 2026
Seaquelle Publishes Financial Results Following Leadership TransitionsAug 6, 2026

EU Markets

European Markets Hit Record Highs, Crypto Goes Institutional, and a German Fintech Joins the Unicorn ClubAug 7, 2026
European Markets Send Mixed Signals: What This Week's Financial Turbulence Means for Startup FoundersJul 31, 2026
European Markets Flash Both Green and Red for Startups: What This Week's Financial Moves Mean for YouJul 24, 2026
Defence Funds, AI Warnings, and a €30B Bank Battle: What Europe's Financial Markets Mean for Your Startup This WeekJul 17, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.